Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Altered immune surveillance of B and T cells in patients with persistent residual lung abnormalities 12 months after severe COVID-19

Fig. 2

Computed tomography of a patient fully recovered group (FRG) and a persistent lung abnormalities group (PLAG). (a) Male, 40 years old, showing ground-glass attenuation and parenchymal consolidation. (b) The same patient showed in (a) but at 1 year of follow-up, asymptomatic and normal pulmonary function. (c) Male, 58 years old, showing diffuse ground glass and some parenchymal consolidation. (d) the same patient showed in (c) at 1 year with dyspnea on exercise, decreased DLCO, persistence of reticular lesions, and lost volume in the left lung

Back to article page